Elutia

Elutia(ELUT)

SILVER SPRING, MD
Biotechnology
WebsiteLinkedInCareers Page

Focus: Drug-eluting biomatrix

Elutia is a life sciences company focused on Drug-eluting biomatrix.

CardiovascularOncologyUnknown
Funding Stage
PUBLIC
Open Jobs
1

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT04299282CIED Implantation in Low BMI Patients
N/A
CIED envelope
Cardiac Disease
N/A
Clinical Trials (1)
NCT04645173Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation
N/A
CanGaroo Envelope
Cardiac Disease
N/A
Clinical Trials (1)
NCT04351269Retrospective Experience Of CIED Implantation
N/A
N/A
Clinical Trials (1)
NCT03425682ViBone in Cervical and Lumbar Spine Fusion
N/A
CorMatrix ECM for Carotid Repair
Carotid Stenosis
N/A
Clinical Trials (1)
NCT01569594CorMatrix ECM for Carotid Repair Following Endarterectomy Registry
N/A
EluPro Antibiotic-Eluting BioEnvelope
Cardiac Arrhythmias
N/A
Clinical Trials (1)
NCT06854081EluPro Antibiotic-Eluting BioEnvelope Registry
N/A
CorMatrix ECM for Vascular Repair
Peripheral Vascular Disease
N/A
Clinical Trials (1)
NCT02418156A Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction
N/A
CorMatrix ECM for Pericardial Closure
Atrial Fibrillation New Onset
N/A
Clinical Trials (1)
NCT01247974Evaluation Of New Onset Postoperative Atrial Fibrillation
N/A
N/A
Clinical Trials (1)
NCT03896347A Study Evaluating 3-Level OLIF Spine Fusion
N/A
SimpliDerm HADM
Breast Cancer
N/A
Clinical Trials (1)
NCT04060134A Retrospective Breast Reconstruction Study
N/A
CorMatrix CanGaroo ECM Envelope
Coronary Disease
N/A
Clinical Trials (1)
NCT02418143A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope
N/A
Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)
Coronary Disease
N/A
Clinical Trials (1)
NCT02073331Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)
N/A
A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope
Cardiovascular Disease
N/A
Clinical Trials (1)
NCT02530970A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope
N/A
CanGaroo Envelope
Arrhythmias, Cardiac
N/A
Clinical Trials (1)
NCT04846127CanGaroo® Registry Study
N/A

Open Jobs (1)

Director, Quality

Gaithersburg, MD
Quality Assurance
2w ago
Interview Prep Quick Facts
Portfolio: 14 clinical trials
SEC Filings: 2 available
Open Roles: 1 active job

Financials (FY2025)

Revenue
$14M42%
R&D Spend
$3M(21%)32%
Net Income
-$54M
Cash
$13M
Source: SEC 10-K Filing